Week Adjourned: 4.15.16 – 24-Hour Fitness, Cold FX, Goldman Sachs

24 Hour FitnessTop Class Action Lawsuits

Fitness Flub…24 hour Fitness has its feet to the fire again, this time—well, as always—it’s a consumer fraud class action lawsuit alleging the national fitness chain raised its customers’ fees for use on lifetime memberships, in violation of various state laws in California, Texas, and Oregon.

Filed by Kevin O’Shea of California, Mark Vitcov of Oregon, and Rod Morris of Texas, individually and for all others similarly situated, the 24 Hour Fitness lawsuit claims sales representatives employ aggressive sales pitches to induce consumers into buying lifetime memberships to its gyms. Under the terms of these lifetime memberships, customers must prepay three years of membership fees, following which they pay only nominal renewal fees.

However, according to the lawsuit, while the annual renewal fees were supposed to remain constant for the rest of the member’s life, when the defendant came under new ownership it stopped honoring its lifetime fee guarantees and announced that it would raise lifetime members’ annual renewal fees beginning in 2016. Can you say “Scamorama?”

The lawsuit alleges fraud, violation of California’s Consumer Legal Remedies Act, its Unfair Competition Law, and its Health Studio Services Contract Law, violation of Oregon’s Unlawful Trade Practices Act, and violation of Texas’s Health Spa Act and its Deceptive Trade Practices Act. The case is US District Court for the Northern District of California San Francisco Division Case number 3:16-CV-01668-EDL.

Placebo FX? A Canadian consumer fraud class action lawsuit to report this week. It was filed against the makers of the popular over-the-counter cold treatment, Cold-FX, alleging the product is no more effective at preventing colds and flu than a placebo. Now there’s a thing.

The Cold FX lawsuit was originally filed by Vancouver Island resident Don Harrison in 2012, against Cold-FX, which is owned by Valeant Pharmaceuticals and its subsidiary, Afexa Life Sciences. The lawsuit cites advertising in which Cold-FX claims to provide “immediate relief of cold and flu” if taken over a three-day period at the first sign of symptoms.

Here’s the rub, according to the complaint, the defendants ignored their own research and misled consumers about the short-term effectiveness of the popular cold and flu remedy. Hey—if it’s true—they wouldn’t be the first.

According to Harrison’s notice of claim, Valeant and Afexa continued to “knowingly or recklessly” promote Cold-FX despite evidence the natural-health product only had a possible positive impact after being taken daily for prolonged periods of two-to-six months. That’s a long lead time for any cold remedy—you would be on this stuff for life, effectively. Or not. Wonder if it’s publicly traded…

The lawsuit claims that people paid money for a worthless product. According to the attorney representing Harrison, Valeant and Afexa failed to release data from an internal study conducted in the early 2000s that contradicted the health claims around Cold-FX. The defendants knew at least as early as 2004, when they had a study done themselves, that Cold-FX might be even less effective than a placebo, the lawsuit alleges.

An identical lawsuit has been filed in Saskatchewan.  

Top Settlements

Goldman Sachs hit with $41 Million Bill…stemming from allegations brought by Illinois Attorney General Lisa Madigan in yet another residential mortgage-backed (RMBS) securities lawsuit. Ka-Ching!

The charges specifically allege misconduct during the bank’s marketing and sale of RMBS prior to the 2008 economic collapse—remember that? Goldman Sachs allegedly failed to disclose the true risk associated with many of its RMBS investments.

According to the terms of the settlement, GS will pay $25 million to the Illinois’ pension system and $16 million will be given in relief to Illinois consumers.

This settlement is part of a larger, $5 billion national settlement resulting from legal action taken by the US Department of Justice and state attorneys general and other entities. 

Ok—That’s a wrap folks…Have a good one. See you at the Bar!


Week Adjourned: 7.17.10

Top Class Actions

Recall on a Rolling Basis. This week’s pharmaceutical lawsuit is against Johnson &Johnson (J&J) alleging fraud and racketeering and demanding compensation for recalled children’s allergy and cold medicines—you remember—the recall that kept going and going—first on April 30th concerning over 40 different types of kiddies cold meds, and then again in June—’oops—we maybe should have recalled these also…’ and once more for good measure in July.

But it’s not the recall that’s the problem apparently, it’s the fact that J&J’s McNeil Consumer Healthcare and McNeil-PPC had offered consumers coupons for refunds of the recalled products, which consumers have rejected, according to the suit.

According to a report on Bloomberg’s Businessweek, the complaint states the coupons are worthless because McNeil has stopped making the medicines and “wrongly assumes that all consumers will want to purchase the company’s children’s products at some uncertain future date.”

So, the suits seek to proceed on behalf of plaintiffs’ groups for residents of Illinois, Texas and Florida, as well as consumers in the U.S. and Canada, who have bought the drugs since December 2008.

Sweating the Glass Ceiling? 24-hour Fitness also got hit with a class action this week brought by its employees over allegations of discrimination on the basis of race, color, national origin and gender.

Apparently this very large chain of fitness facilities—as in 400 fitness centers, Continue reading “Week Adjourned: 7.17.10”